SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Dadra Facility Receives OAI Status From US FDA

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1595.2000 -36.90 (-2.26%)

NSE Aug 06, 2025 15:59 PM

Near 52W Low of ₹1553.05

Volume: 2.4M

Sun Pharmaceutical Industries Ltd.

11 Apr 2024

1595.20

-2.26%

Company Update

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Intimation regarding Regulatory order

More from Sun Pharmaceutical Industries Ltd.

Recommended

Market closes lower, Lupin's Q1 net profit surges 52.1% YoY to Rs 1,219 crore

Trendlyne Marketwatch | 06 Aug 2025, 03:56PM

Five stocks to buy from analysts this week - August 6, 2025

The Baseline | 06 Aug 2025, 10:55AM

Change is hard, and some Indian pharma companies are embracing it better than others